M&A Deal Summary

CEE Equity Partners Acquires Electronic Control Systems

On January 1, 2015, private equity firm CEE Equity Partners acquired communications company Electronic Control Systems

Acquisition Highlights
  • This is CEE Equity Partners’ 1st transaction in the Communications sector.
  • This is CEE Equity Partners’ 1st transaction in Poland.

M&A Deal Summary

Date 2015-01-01
Target Electronic Control Systems
Sector Communications
Buyer(s) CEE Equity Partners
Deal Type Buyout (LBO, MBO, MBI)

Target

Electronic Control Systems

Balice, Poland
Electronic Control Systems is a provider of services for the telecommunications sector. The company provides turnkey services for mobile operators in Poland and several other foreign markets (construction works, acquisition of locations and securing permits, building networks and installations, optimisation of RANs, networks tests, electromagnetic field measurements and traffic maintenance and management). Electronic Control Systems was founded in 1999 and is based in Balice, Poland.

Search 215,029 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

CEE Equity Partners

Investor Investor Investor Investor Investor


Category Private Equity Firm
Founded 2013
PE ASSETS 1.2B USD
Size Large
Type Sector Agnostic
DESCRIPTION

CEE Equity Partners is a private investment firm focused on investing in a variety of investments in Central and Eastern Europe. Sectors of interest include renewable energy, energy efficiency, healthcare, manufacturing, infrastructure, and transportation. CEE Equity Partners was formed in 2013 and is based in Nicosia, Cyprus.


DEAL STATS #
Overall 1 of 10
Sector: Communications M&A 1 of 2
Type: Buyout (LBO, MBO, MBI) M&A Deals 1 of 5
Country: Poland M&A 1 of 4
Year: 2015 M&A 1 of 2
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2015-07-31 Bioton

Ozarow Mazowiecki, Poland

Bioton is a dynamic and developing Polish company in the biotechnology sector, manufacturing clinically important modern drugs, including recombinant human insulin and its pharmaceutical forms, as well as preparations from the cephalosporine, aminoglycoside and macrolide groups. Bioton is based in Ozarow Mazowiecki, Poland.

Buy -